Health Technology Assessment

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

  • Type:
    Extended Research Article
  • Authors:
    Chen Y, Jobanputra P, Barton P, Jowett S, Bryan S, et al.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 10, Issue: 42
  • Published:
  • Citation:
    Chen Y, Jobanputra P, Barton P, Jowett S, Bryan S, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006;10(42). https://doi.org/10.3310/hta10420
  • DOI:
    https://doi.org/10.3310/hta10420
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates